Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is one of the 11 Best Short-Term Stocks to Invest in. The company’s weekly stock ...

Tom Siebel, c3.ai CEO, joins 'Closing Bell Overtime' to talk quarterly results, recent stock performance, restructuring sales ...

C3.ai reported preliminary Q1 results after the bell on Friday, triggering a 30% crash intra-day on Monday. Click here to ...

C3.ai fell for a fourth straight day on Monday, slashing 25.58 percent to close at $16.47 apiece after its chief executive called the preliminary results of its first quarter of fiscal year 2026 ...

U.S. equities were up at midday, with the Nasdaq and S&P 500 trading at record highs, as consumer inflation rose less than ...

The company, which sells artificial-intelligence analytics products to the national security, defense and manufacturing industries, acknowledged Monday afternoon that cutbacks by customers who support ...

C3.ai stock was plunging as it said quarterly revenue would fall way below expectations. There are further problems ahead.

U.S. stocks are drifting near their record heights as Wall Street waits for an upcoming update on inflation. NEW YORK (AP) — ...

Shares of C3.ai plunged after the AI software provider posted weak preliminary financial results that fell well short of even ...

U.S. stocks edged back from their record heights in Wall Street’s final moves before an upcoming update on inflation.

While it's likely the company will continue to struggle, C3.ai stock now trades at a discount compared to much of the ...

C3.ai reported expected revenue of $70.2 million to $70.4 million, down 19% year-over-year from $87.2 million in the year-ago ...